Bookmark and Share

Compound Summary for: CID 3081361

Vandetanib

Also known as: Zactima, 443913-73-3, ZD6474, Caprelsa, ZD 6474, ZD-6474, 2ivu
Molecular Formula: C22H24BrFN4O2   Molecular Weight: 475.353963   InChIKey: UHTHHESEBZOYNR-UHFFFAOYSA-N
Vandetanib is an oral once-daily kinase inhibitor of tumour angiogenesis and tumour cell proliferation with the potential for use in a broad range of tumour types. On April 6 2011, vandetanib was approved by the FDA to treat nonresectable, locally advanced, or metastatic medullary thyroid cancer in adult patients.    From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Use and Manufacturing
Literature
Patents
Biomolecular Interactions and Pathways
Biological Test Results
Classification
Chemical and Physical Properties
_ _